Prevalence and Predictors of Deep Vein Thrombosis in Critically Ill Medical Patients Who Underwent Diagnostic Duplex Ultrasonography

Abstract

Introduction:

Deep vein thrombosis (DVT) is a recognized but preventable cause of morbidity and mortality in the medical intensive care unit (MICU). We examined the prevalence and risk factors for DVT in MICU patients who underwent diagnostic venous duplex ultrasonography (DUS) and the potential effect on clinical outcomes.

Methods:

This is a retrospective study examining prevalence of DVT in 678 consecutive patients admitted to a tertiary care level academic MICU from July 2014 to 2015. Patients who underwent diagnostic DUS were included. Potential conditions of interest were mechanical ventilation, hemodialysis, sepsis, Sequential Organ Failure Assessment (SOFA) scores, central venous catheters, prior DVT, and malignancy. Primary outcomes were pulmonary embolism, ICU length of stay, and mortality. Additionally, means of thromboprophylaxis was compared between the groups. Multivariable logistic regression analysis was utilized to determine predictors of DVT occurrence.

Results:

Of the 678 patients, 243 (36%) patients underwent DUS to evaluate for DVT. The prevalence of DVT was 16% (38) among tested patients, and a prior history of DVT was associated with DVT prevalence (P < .01). Between cases and controls, there were no significant differences in central venous catheters, mechanical ventilation, hemodialysis, sepsis, SOFA scores, malignancy, and recent surgery. Patients receiving chemical prophylaxis had fewer DVTs compared to persons with no prophylaxis (14% vs 29%; P = .01) and persons with dual chemical and mechanical prophylaxis (P = 0.1). Fourteen percent of patients tested had documented DVT while on chemoprophylaxis. There were no significant differences in ICU length of stay (P = .35) or mortality (P = .34).

Conclusions:

Despite the appropriate use of universal thromboprophylaxis, critically ill nonsurgical patients still demonstrated high rates of DVT. A history of DVT was the sole predictor for development of proximal DVT on DUS testing. Dual chemical and mechanical prophylaxis does not appear to be superior to single-chemical prophylaxis in DVT prevention in this population.

Keywords

ICU outcomes medical ICU deep venous thrombosis

Get full access to this article

View all access options for this article.

References

Mahan

Holdsworth

Welch

Borrego

Spyropoulos

. Deep-vein thrombosis: a United States cost model for a preventable and costly adverse event. Thromb Haemost. 2011;106(3):405–415.

Attia

Ray

Cook

Douketis

Ginsberg

Geerts

. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med. 2001;161(10):1268–1279.

Sandler

Martin

. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med. 1989;82(4):203–205.

Moser

LeMoine

Nachtwey

Spragg

. Deep venous thrombosis and pulmonary embolism. Frequency in a respiratory intensive care unit. JAMA. 1981;246(13):1422–1424.

Cade

. High risk of the critically ill for venous thromboembolism. Crit Care Med. 1982;10(7):448–450.

Fraisse

Holzapfel

Couland

, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The association of non-university affiliated intensive care specialist physicians of france. Am J Respir Crit Care Med. 2000;161(4 pt 1):1109–1114.

Lawall

Oberacker

Zemmrich

Bramlage

Diehm

Schellong

. Prevalence of deep vein thrombosis in acutely admitted ambulatory non-surgical intensive care unit patients. BMC Res Notes. 2014;7:431.

Kaplan

Casper

Elliott

, et al. VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest. 2015;148(5):1224–1230.

Quezada

Bikdeli

Barrios

, et al. Assessment of coexisting deep vein thrombosis for risk stratification of acute pulmonary embolism. Thromb Res. 2018;164:40–44.

10.

Lucas

Silva

EED

Souza

DOD

Santos

ARD

Lara

. Microstructural evaluation by confocal and electron microscopy in thrombi developed in central venous catheters. Rev Esc Enferm USP. 2017;51:e03247.

11.

Kujur

Rao

Badwaik

Paraswani

. Thrombosis associated with right internal jugular central venous catheters: a prospective observational study. Indian J Crit Care Med. 2012;16(1):17–21.

12.

Stuck

Spirk

Schaudt

Kucher

. Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review. Thromb Haemost. 2017;117(4):801–808.

13.

PROTECT Investigators for the Canadian Critical Care Trials Group, the Australian and New Zealand Intensive Care Society Clinical Trials Group, Cook

Meade

Guyatt

, et al. Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med. 2011;364(14):1305–1314.